{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:21:57Z","timestamp":1786123317428,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1213\/ane.0000000000000064","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T03:12:44Z","timestamp":1390273964000},"page":"243-246","source":"Crossref","is-referenced-by-count":1,"title":["Hot on the Trail of \u201cI know it when I see it!\u201d"],"prefix":"10.1213","volume":"118","author":[{"given":"Jerome","family":"Parness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210902","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1213\/ANE.0b013e3182a8fad0","article-title":"Malignant hyperthermia in children: an analysis of the North American Malignant Hyperthermia Registry.","volume":"118","author":"Nelson","year":"2014","journal-title":"Anesth Analg"},{"key":"R2-1-20210902","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1213\/ANE.0000000000000062","article-title":"Anesthetic drugs and onset of malignant hyperthermia.","volume":"118","author":"Visoiu","year":"2014","journal-title":"Anesth Analg"},{"key":"R6-1-20210902","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1213\/ane.0b013e3181a7c8e5","article-title":"The myotonias and susceptibility to malignant hyperthermia.","volume":"109","author":"Parness","year":"2009","journal-title":"Anesth Analg"},{"key":"R7-1-20210902","doi-asserted-by":"crossref","first-page":"a003996","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release.","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R8-1-20210902","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/bja\/aer132","article-title":"Malignant hyperthermia: pharmacology of triggering.","volume":"107","author":"Hopkins","year":"2011","journal-title":"Br J Anaesth"},{"key":"R9-1-20210902","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility.","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R10-1-20210902","first-page":"141","article-title":"Opportunities and pitfalls of registry data for clinical research.","volume":"14","author":"Psoter","year":"2013","journal-title":"Paediatr Respir Rev"},{"key":"R11-1-20210902","first-page":"296","article-title":"Fatal recrudescence of malignant hyperthermia in an infant with Moebius syndrome.","volume":"63","author":"Fernandes","year":"2013","journal-title":"Rev Bras Anestesiol"},{"key":"R12-1-20210902","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-6576.2011.02573.x","article-title":"The severity of sevoflurane-induced malignant hyperthermia.","volume":"56","author":"Migita","year":"2012","journal-title":"Acta Anaesthesiol Scand"},{"key":"R13-1-20210902","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1213\/ANE.0b013e31820b5f1f","article-title":"Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.","volume":"112","author":"Brandom","year":"2011","journal-title":"Anesth Analg"},{"key":"R14-1-20210902","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1213\/ANE.0b013e3181c6b9b2","article-title":"Clinical presentation, treatment, and complications of malignant hyperthermia in North America from 1987 to 2006.","volume":"110","author":"Larach","year":"2010","journal-title":"Anesth Analg"},{"key":"R15-1-20210902","doi-asserted-by":"crossref","first-page":"48077","DOI":"10.1074\/jbc.M107134200","article-title":"B-lymphocytes from malignant hyperthermia-susceptible patients have an increased sensitivity to skeletal muscle ryanodine receptor activators.","volume":"276","author":"Girard","year":"2001","journal-title":"J Biol Chem"},{"key":"R16-1-20210902","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/00000542-200211000-00005","article-title":"Patients with malignant hyperthermia demonstrate an altered calcium control mechanism in B lymphocytes.","volume":"97","author":"Sei","year":"2002","journal-title":"Anesthesiology"},{"key":"R17-1-20210902","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1213\/ANE.0b013e31828a71ff","article-title":"Ryanodine receptor type 1 gene variants in the malignant hyperthermia-susceptible population of the United States.","volume":"116","author":"Brandom","year":"2013","journal-title":"Anesth Analg"},{"key":"R18-1-20210902","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1213\/01.ANE.0000118110.90277.D2","article-title":"4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.","volume":"99","author":"Weigl","year":"2004","journal-title":"Anesth Analg"},{"key":"R19-1-20210902","doi-asserted-by":"crossref","first-page":"33477","DOI":"10.1074\/jbc.M602306200","article-title":"Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor.","volume":"281","author":"Zhao","year":"2006","journal-title":"J Biol Chem"},{"key":"R20-1-20210902","doi-asserted-by":"crossref","first-page":"25645","DOI":"10.1074\/jbc.M110.104976","article-title":"Store-operated Ca2 entry in malignant hyperthermia-susceptible human skeletal muscle.","volume":"285","author":"Duke","year":"2010","journal-title":"J Biol Chem"},{"key":"R21-1-20210902","doi-asserted-by":"crossref","first-page":"31624","DOI":"10.1074\/jbc.R112.349068","article-title":"Ryanodine receptors: structure and function.","volume":"287","author":"Van Petegem","year":"2012","journal-title":"J Biol Chem"},{"key":"R22-1-20210902","doi-asserted-by":"crossref","first-page":"7923","DOI":"10.1073\/pnas.1119207109","article-title":"Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2 channel and the type 1 ryanodine receptor.","volume":"109","author":"Eltit","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-1-20210902","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1096\/fj.12-218354","article-title":"Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia.","volume":"27","author":"Eltit","year":"2013","journal-title":"Faseb J"},{"key":"R24-1-20210902","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/ALN.0b013e3182320068","article-title":"Identical de novo mutation in the type 1 ryanodine receptor gene associated with fatal, stress-induced malignant hyperthermia in two unrelated families.","volume":"115","author":"Groom","year":"2011","journal-title":"Anesthesiology"},{"key":"R25-1-20210902","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1213\/ANE.0b013e3182768f99","article-title":"Case report: Death in the emergency department: an unrecognized awake malignant hyperthermia-like reaction in a six-year-old.","volume":"116","author":"Lavezzi","year":"2013","journal-title":"Anesth Analg"},{"key":"R26-1-20210902","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/pan.12224","article-title":"Unexpected MH deaths without exposure to inhalation anesthetics in pediatric patients.","volume":"23","author":"Brandom","year":"2013","journal-title":"Paediatr Anaesth"},{"key":"R27-1-20210902","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.bbamcr.2011.08.001","article-title":"Malignant hyperthermia: human stress triggering.","volume":"1813","author":"Gronert","year":"2011","journal-title":"Biochim Biophys Acta"}],"container-title":["Anesthesia & Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000000064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:15Z","timestamp":1786112535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201402000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000000064","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}